
Special Issues
Recently, the attention of the U.S. Pharmacopeia (USP) has turned to the elemental impurities found in drug products. Before its most recent activities, USP methods for determining elemental impurities have relied upon outdated methodology that is qualitative, relatively insensitive, and can be used only for the determination of a subset of the toxic elements that should be quantified (USP Chapter <231> - Heavy Metals). Proposed changes have been made that utilize modern analytical techniques for measuring a larger number of heavy metals at toxicologically relevant concentrations. As of this publication, the expected date for implementing changes to USP Chapter <231> is September 2013.


























